Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000223485 | SCV000275292 | likely benign | Hereditary cancer-predisposing syndrome | 2022-01-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000588455 | SCV000695172 | uncertain significance | not provided | 2016-03-01 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000588455 | SCV000889163 | uncertain significance | not provided | 2018-05-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001857377 | SCV002127509 | likely benign | Hereditary breast ovarian cancer syndrome | 2024-04-10 | criteria provided, single submitter | clinical testing | |
Breast Cancer Information Core |
RCV000113990 | SCV000147445 | uncertain significance | Breast-ovarian cancer, familial, susceptibility to, 2 | 2004-02-20 | no assertion criteria provided | clinical testing |